21st European Symposium on Quantitative Structure-Activity Relationship
Where Molecular Simulations Meet Drug Discovery
Aptuit Conference Center
Verona, Italy September 4-8, 2016
University of Bologna and IIT, Bologna, Italy
University of Parma, Parma, Italy
University of Vienna, Vienna, Austria
GSK, Hinxton, United Kingdom
Umea University, Umea, Sweden
University of New Mexico, Albuquerque, United States
Institute for Research in Biomedicine (IRB), Barcelona, Spain
Institute of Biomedical Chemistry, Moscow, Russia
University of North Carolina, Chapel Hill, United States
Cornell University, New York, United States
Ankara University, Ankara, Turkey
InnoSA GmbH, Groß-Zimmern, Germany
Sanofi, Frankfurt, Germany
Dompé Pharma, L'Aquila, Italy
University of Cambridge, United Kingdom
University of Siena, Siena, Italy
Karolinska Institutet, Barcelona, Spain
University of Oslo, Oslo, Norway
Liverpool John Moores University, Liverpool, United Kingdom
Ecole polytechnique fédérale de Lausanne, Lausanne, Switzerland
Novartis Institute for Biomedical Research, Basel, Switzerland
exeResearch LLC, East Lansing, United States
University of New Mexico, South San Francisco, CA, United States
European Molecular Biology Laboratory, Cambridgeshire, United Kingdom
Sanofi-Aventis Deutschland, Frankfurt am Main, Germany
Bayer, Monheim am Rhein, Germany
Leiden University, Leiden, The Netherlands
Janssen, Beerse, Belgium
Yale University, New Haven, United States
Philipps-University Marburg, Marburg, Germany
Boehringer-Ingelheim, Biberach, Germany
University of Vienna, Vienna, Austria
Novartis Pharmaceuticals, Basel, Switzerland
University of Barcelona, Barcelona, Spain
University of Perugia, Perugia, Italy
Monash University, Parkville, Australia
Martin Consulting, Waukegan, United States
Heptares Therapeutics, Cambridge, United Kingdom
IMIM Hospital del Mar Medical Research Institute, Girona, Spain
National Cancer Institute, Frederick, United States
The Hebrew University, Rehovot, Israel
Stratified Medical, Oxford , United Kingdom
Institute of Physiologically Active Compouds, Moscow, Russia
University of Hambourg, Hamburg, Germany
University of Bologna, Bologna, Italy
University Pompeu Fabra, Barcelona, Spain
ETH Zürich, Zürich, Switzerland
Pfizer Global Research and Development, Cambridge, MA, United States
University of Toronto, San Francisco CA, Canada
Martin-Luther-Universität Halle-Wittenberg, Halle, Germany
Hoffmann-La Roche, Basel, Switzerland
University of Athens, Athens, Greece
EMBL, Heidelberg, Germany
University of Strasbourg, Strasbourg, France
Eli Lilly & Co, Indianapolis, United States
Heidelberg University and HITS, Heidelberg, Germany
Shanghai Institute of Organic Chemistry, Shanghai, China
CSIRO Manufacturing, Clayton, Australia
Ankara University, Ankara, Turkey
Italian Institute of Technology, Genova, Italy
University of Parma, Parma, Italy
Italian Institute of Technology, Genova, Italy
Aptuit, Verona, Italy
University of Parma, Parma, Italy
University of Bologna, Bologna, Italy